CELESTICA INC (CLS) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:CLS - CA15101Q2071 - Common Stock
280.06 USD
-2.22 (-0.79%)
282.14 USD
+2.08 (+0.74%)
ChartMill assigns a Buy % Consensus number of 81% to CLS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 248.47. This target is -11.28% below the current price.
CLS was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about CLS.
In the previous month the buy percentage consensus was at a similar level.
CLS was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-10 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-10-29 | CIBC | Maintains | Outperformer -> Outperformer |
| 2025-10-29 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-29 | Stifel | Reiterate | Buy -> Buy |
| 2025-10-29 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-29 | TD Securities | Maintains | Hold -> Hold |
| 2025-10-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-22 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-20 | CIBC | Maintains | Outperformer -> Outperformer |
| 2025-10-16 | Goldman Sachs | Initiate | Buy |
| 2025-10-03 | TD Cowen | Reiterate | Hold |
| 2025-10-03 | TD Securities | Downgrade | Buy -> Hold |
| 2025-09-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-19 | CICC | Initiate | Outperform |
| 2025-07-30 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-30 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-21 | Citigroup | Initiate | Neutral |
| 2025-07-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-06-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-22 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-04-29 | Argus Research | Maintains | Buy -> Buy |
| 2025-04-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-04-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-28 | JP Morgan | Maintains | Overweight -> Overweight |
CELESTICA INC / CLS FAQ
What do analysts expect the price target to be for CELESTICA INC (CLS)?
18 analysts have analysed CLS and the average price target is 248.47 USD. This implies a price decrease of -11.28% is expected in the next year compared to the current price of 280.06.
Can you provide the consensus rating for CELESTICA INC stock?
The consensus rating for CELESTICA INC (CLS) is 81.1111 / 100 . This indicates that analysts generally have a positive outlook on the stock.